Dr Lal PathLabs

quarterly
yearly
ParticularsDec '21Mar '22Jun '22Sep '22Dec '22
Revenue496.90485.51502.70533.80489.40
Expenses418.40402.09421.10428.80414.30
EBITDA78.5083.4281.60105.0075.10
EBIT47.8045.7145.7066.2037.20
Profit Before Tax81.5083.5881.40102.8076.50
Net Profit57.3061.3357.7071.7052.80
Financial Ratios
Operating Profit Margin15.80%17.18%16.23%19.67%15.35%
Net Profit Margin11.53%12.63%11.48%13.43%10.79%
Earning Per Share (Diluted)6.907.416.968.606.35
Dividends Per ShareNA6.00NA6.00NA
ⓒ 2016-2023 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 3.7.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI